MiNK Therapeutics Inc. Gains 53.05%

Tue, Feb 04, 2025 at 07:29 PM

MiNK Therapeutics Inc. (INKT:NASDAQ) rocketted at $12.03, a gain of 53.1%. On Tue, Feb 04, 2025, INKT:NASDAQ touched a New 2-Week High of $12.03. The stock got featured on our News Catalysts scanner on Thu, Jan 23, 2025 at 03:51 PM in the 'BIOTECH' category. From Wed, Jan 22, 2025, the stock recorded 37.50% Up Days and 44.44% Green Days

About MiNK Therapeutics Inc. (INKT:NASDAQ)

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other life-threatening...

Top 10 Gainers:

Captivision Inc. (CAPT:NASDAQ), 139.18%
Quantum Biopharma Ltd. (QNTM:NASDAQ), 111.01%
Lottery.com Inc. (LTRY:NASDAQ), 88.33%
Cumberland Pharmaceuticals Inc. (CPIX:NASDAQ), 76.53%
MiNK Therapeutics Inc. (INKT:NASDAQ), 53.05%
Lixiang Education Holding Co. Ltd. (LXEH:NASDAQ), 50.56%
Yoshiharu Global Co. (YOSH:NASDAQ), 47.55%
Direxion Daily PLTR Bull 2X Shares (PLTU:NASDAQ), 47.11%
Evaxion Biotech A/S (EVAX:NASDAQ), 36.25%
Beyond, Inc. (BYON:NYSE), 33.33%